SYRA HEALTH CORP. Research and Development Expense
SYRA HEALTH CORP. (SYRA) reported Research and Development Expense of $47.35 thousand for the 3-month period ending 2026-06-30, per its S-1 filed 2026-09-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-09-14
- SYRA HEALTH CORP. research and development expense for the quarter ending 2026-06-30 was $47.35K, a 59.37% increase year-over-year.
- SYRA HEALTH CORP. research and development expense for the quarter ending 2026-03-31 was $6.92K, a 81.38% decline year-over-year.
- SYRA HEALTH CORP. research and development expense for the quarter ending 2025-12-31 was $139.00.
- SYRA HEALTH CORP. research and development expense for the quarter ending 2025-09-30 was $816.00, a 97.66% decline year-over-year.
- SYRA HEALTH CORP. research and development expense for fiscal 2023 was $240.05K.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $47.35K S-1 · filed 2026-09-14 | $54.27K S-1 · filed 2026-09-14 | $54.41K derived: sum of 3 quarters · filed 2026-09-14 | $55.23K derived: sum of 4 quarters · filed 2026-09-14 |
| 2026-03-31 | $6.92K 10-Q · filed 2026-05-07 | $7.06K derived: sum of 2 quarters · filed 2026-09-14 | $7.88K derived: sum of 3 quarters · filed 2026-09-14 | $37.59K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-12-31 | $139.00 derived: S-1 12 month − 10-Q 9 month · filed 2026-09-14 | $955.00 derived: sum of 2 quarters · filed 2026-09-14 | $30.67K derived: sum of 3 quarters · filed 2026-09-14 | $67.84K S-1 · filed 2026-09-14 |
| 2025-09-30 | $816.00 10-Q · filed 2025-11-12 | $30.53K derived: sum of 2 quarters · filed 2026-09-14 | $67.70K 10-Q · filed 2025-11-12 | $62.58K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-06-30 | $29.71K S-1 · filed 2026-09-14 | $66.89K S-1 · filed 2026-09-14 | $61.77K derived: sum of 3 quarters · filed 2026-09-14 | $96.59K derived: sum of 4 quarters · filed 2026-09-14 |
| 2025-03-31 | $37.17K 10-Q · filed 2026-05-07 | $32.06K derived: sum of 2 quarters · filed 2026-09-14 | $66.88K derived: sum of 3 quarters · filed 2026-09-14 | $344.77K derived: sum of 4 quarters · filed 2026-09-14 |
| 2024-12-31 | -$5.12K derived: S-1 12 month − 10-Q 9 month · filed 2026-09-14 | $29.70K derived: sum of 2 quarters · filed 2026-09-14 | $307.60K derived: sum of 3 quarters · filed 2026-09-14 | $585.15K S-1 · filed 2026-09-14 |
| 2024-09-30 | $34.82K 10-Q · filed 2025-11-12 | $312.71K derived: sum of 2 quarters · filed 2025-11-12 | $590.26K 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $277.89K 10-Q · filed 2025-08-12 | $555.44K 10-Q · filed 2025-08-12 | ||
| 2024-03-31 | $277.55K 10-Q · filed 2025-05-08 | |||
| 2023-12-31 | $240.05K 10-K · filed 2025-03-11 |